(CNNE) Cannae Holdings - Ratings and Ratios
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US13765N1072
Restaurants, Healthcare, Financial Services
Dividends
| Dividend Yield | 4.03% |
| Yield on Cost 5y | 1.62% |
| Yield CAGR 5y | 0.00% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
| Risk via 10d forecast | |
|---|---|
| Volatility | 30.3% |
| Value at Risk 5%th | 48.8% |
| Relative Tail Risk | -1.90% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.67 |
| Alpha | -34.25 |
| CAGR/Max DD | -0.20 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.591 |
| Beta | 0.884 |
| Beta Downside | 0.997 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.35% |
| Mean DD | 21.02% |
| Median DD | 21.90% |
Description: CNNE Cannae Holdings November 16, 2025
Cannae Holdings, Inc. (NYSE:CNNE) is a Las Vegas-based principal investment firm founded in 2014. It deploys capital across a multi-sector portfolio-including restaurant chains, technology-enabled healthcare services, and financial services-taking both minority and majority equity positions.
Key metrics that analysts monitor include CNNE’s cash-on-cash return (historically targeting 12-15% IRR) and its portfolio turnover rate, which has averaged roughly 1.8 × per year since inception. The firm’s exposure to consumer discretionary (restaurants) is sensitive to discretionary spending trends, while its technology-enabled healthcare assets benefit from rising tele-health adoption, a sector projected to grow at a CAGR of ~14% through 2028. Additionally, CNNE’s financial services investments are linked to the broader credit market environment, where net interest margin compression could pressure returns.
For a deeper dive into CNNE’s valuation metrics and scenario analysis, you might explore the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 1.5
| Net Income (-466.3m TTM) > 0 and > 6% of Revenue (6% = 25.8m TTM) |
| FCFTA -0.03 (>2.0%) and ΔFCFTA 0.32pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 31.26% (prev 28.27%; Δ 2.99pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.03 (>3.0%) and CFO -40.6m > Net Income -466.3m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 2.03 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (54.7m) change vs 12m ago -12.34% (target <= -2.0% for YES) |
| Gross Margin -2.91% (prev 3.03%; Δ -5.94pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 22.64% (prev 20.20%; Δ 2.44pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -17.22 (EBITDA TTM -222.7m / Interest Expense TTM 14.5m) >= 6 (WARN >= 3) |
Altman Z'' 0.38
| (A) 0.09 = (Total Current Assets 265.1m - Total Current Liabilities 130.6m) / Total Assets 1.51b |
| (B) 0.08 = Retained Earnings (Balance) 123.5m / Total Assets 1.51b |
| (C) -0.13 = EBIT TTM -249.7m / Avg Total Assets 1.90b |
| (D) 0.40 = Book Value of Equity 132.3m / Total Liabilities 331.6m |
| Total Rating: 0.38 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 21.07
| 1. Piotroski 1.50pt |
| 2. FCF Yield -6.17% |
| 3. FCF Margin -11.48% |
| 4. Debt/Equity 0.17 |
| 5. Debt/Ebitda 0.11 |
| 6. ROIC - WACC (= -21.63)% |
| 7. RoE -30.34% |
| 8. Rev. Trend -95.56% |
| 9. EPS Trend -17.03% |
What is the price of CNNE shares?
As of December 06, 2025, the stock is trading at USD 16.38 with a total of 619,779 shares traded.
Over the past week, the price has changed by +1.74%, over one month by -7.98%, over three months by -11.91% and over the past year by -19.00%.
Over the past week, the price has changed by +1.74%, over one month by -7.98%, over three months by -11.91% and over the past year by -19.00%.
Is CNNE a buy, sell or hold?
Cannae Holdings has received a consensus analysts rating of 4.50.
Therefore, it is recommended to buy CNNE.
- Strong Buy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CNNE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 20.5 | 25.2% |
| Analysts Target Price | 20.5 | 25.2% |
| ValueRay Target Price | 16.2 | -1.4% |
CNNE Fundamental Data Overview November 24, 2025
Market Cap USD = 824.4m (824.4m USD * 1.0 USD.USD)
P/E Forward = 74.0741
P/S = 1.9164
P/B = 0.6726
Beta = 1.135
Revenue TTM = 430.2m USD
EBIT TTM = -249.7m USD
EBITDA TTM = -222.7m USD
Long Term Debt = 61.7m USD (from longTermDebt, last quarter)
Short Term Debt = 22.1m USD (from shortTermDebt, last quarter)
Debt = 210.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -23.7m USD (from netDebt column, last quarter)
Enterprise Value = 800.7m USD (824.4m + Debt 210.1m - CCE 233.8m)
Interest Coverage Ratio = -17.22 (Ebit TTM -249.7m / Interest Expense TTM 14.5m)
FCF Yield = -6.17% (FCF TTM -49.4m / Enterprise Value 800.7m)
FCF Margin = -11.48% (FCF TTM -49.4m / Revenue TTM 430.2m)
Net Margin = -108.4% (Net Income TTM -466.3m / Revenue TTM 430.2m)
Gross Margin = -2.91% ((Revenue TTM 430.2m - Cost of Revenue TTM 442.7m) / Revenue TTM)
Gross Margin QoQ = 5.80% (prev -15.25%)
Tobins Q-Ratio = 0.53 (Enterprise Value 800.7m / Total Assets 1.51b)
Interest Expense / Debt = 1.57% (Interest Expense 3.30m / Debt 210.1m)
Taxrate = 5.94% (-3.80m / -64.0m)
NOPAT = -234.9m (EBIT -249.7m * (1 - 5.94%)) [loss with tax shield]
Current Ratio = 2.03 (Total Current Assets 265.1m / Total Current Liabilities 130.6m)
Debt / Equity = 0.17 (Debt 210.1m / totalStockholderEquity, last quarter 1.21b)
Debt / EBITDA = 0.11 (negative EBITDA) (Net Debt -23.7m / EBITDA -222.7m)
Debt / FCF = 0.48 (negative FCF - burning cash) (Net Debt -23.7m / FCF TTM -49.4m)
Total Stockholder Equity = 1.54b (last 4 quarters mean from totalStockholderEquity)
RoA = -30.79% (Net Income -466.3m / Total Assets 1.51b)
RoE = -30.34% (Net Income TTM -466.3m / Total Stockholder Equity 1.54b)
RoCE = -15.62% (EBIT -249.7m / Capital Employed (Equity 1.54b + L.T.Debt 61.7m))
RoIC = -13.95% (negative operating profit) (NOPAT -234.9m / Invested Capital 1.68b)
WACC = 7.69% (E(824.4m)/V(1.03b) * Re(9.27%) + D(210.1m)/V(1.03b) * Rd(1.57%) * (1-Tc(0.06)))
Discount Rate = 9.27% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -11.66%
Fair Price DCF = unknown (Cash Flow -49.4m)
EPS Correlation: -17.03 | EPS CAGR: 1.78% | SUE: -0.66 | # QB: 0
Revenue Correlation: -95.56 | Revenue CAGR: -13.22% | SUE: 0.21 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.45 | Chg30d=-0.150 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=-1.81 | Chg30d=-0.390 | Revisions Net=-1 | Growth EPS=+76.2% | Growth Revenue=-4.5%
P/E Forward = 74.0741
P/S = 1.9164
P/B = 0.6726
Beta = 1.135
Revenue TTM = 430.2m USD
EBIT TTM = -249.7m USD
EBITDA TTM = -222.7m USD
Long Term Debt = 61.7m USD (from longTermDebt, last quarter)
Short Term Debt = 22.1m USD (from shortTermDebt, last quarter)
Debt = 210.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -23.7m USD (from netDebt column, last quarter)
Enterprise Value = 800.7m USD (824.4m + Debt 210.1m - CCE 233.8m)
Interest Coverage Ratio = -17.22 (Ebit TTM -249.7m / Interest Expense TTM 14.5m)
FCF Yield = -6.17% (FCF TTM -49.4m / Enterprise Value 800.7m)
FCF Margin = -11.48% (FCF TTM -49.4m / Revenue TTM 430.2m)
Net Margin = -108.4% (Net Income TTM -466.3m / Revenue TTM 430.2m)
Gross Margin = -2.91% ((Revenue TTM 430.2m - Cost of Revenue TTM 442.7m) / Revenue TTM)
Gross Margin QoQ = 5.80% (prev -15.25%)
Tobins Q-Ratio = 0.53 (Enterprise Value 800.7m / Total Assets 1.51b)
Interest Expense / Debt = 1.57% (Interest Expense 3.30m / Debt 210.1m)
Taxrate = 5.94% (-3.80m / -64.0m)
NOPAT = -234.9m (EBIT -249.7m * (1 - 5.94%)) [loss with tax shield]
Current Ratio = 2.03 (Total Current Assets 265.1m / Total Current Liabilities 130.6m)
Debt / Equity = 0.17 (Debt 210.1m / totalStockholderEquity, last quarter 1.21b)
Debt / EBITDA = 0.11 (negative EBITDA) (Net Debt -23.7m / EBITDA -222.7m)
Debt / FCF = 0.48 (negative FCF - burning cash) (Net Debt -23.7m / FCF TTM -49.4m)
Total Stockholder Equity = 1.54b (last 4 quarters mean from totalStockholderEquity)
RoA = -30.79% (Net Income -466.3m / Total Assets 1.51b)
RoE = -30.34% (Net Income TTM -466.3m / Total Stockholder Equity 1.54b)
RoCE = -15.62% (EBIT -249.7m / Capital Employed (Equity 1.54b + L.T.Debt 61.7m))
RoIC = -13.95% (negative operating profit) (NOPAT -234.9m / Invested Capital 1.68b)
WACC = 7.69% (E(824.4m)/V(1.03b) * Re(9.27%) + D(210.1m)/V(1.03b) * Rd(1.57%) * (1-Tc(0.06)))
Discount Rate = 9.27% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -11.66%
Fair Price DCF = unknown (Cash Flow -49.4m)
EPS Correlation: -17.03 | EPS CAGR: 1.78% | SUE: -0.66 | # QB: 0
Revenue Correlation: -95.56 | Revenue CAGR: -13.22% | SUE: 0.21 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.45 | Chg30d=-0.150 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=-1.81 | Chg30d=-0.390 | Revisions Net=-1 | Growth EPS=+76.2% | Growth Revenue=-4.5%
Additional Sources for CNNE Stock
News:
Wall Street Journal |
Benzinga |
Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle